Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

EGX:CPCI Revenue

Kahira Pharmaceuticals & Chemical Industries Company had revenue of 653.05M EGP in the quarter ending September 30, 2025, with 54.72% growth. This brings the company's revenue in the last twelve months to 2.31B, up 59.59% year-over-year. In the fiscal year ending June 30, 2025, Kahira Pharmaceuticals & Chemical Industries Company had annual revenue of 2.08B with 52.80% growth.

• Revenue (ttm): 2.31B
• Revenue Growth: +59.59%
• P/S Ratio: 1.73
• Revenue / Employee: 1.33M
• Employees: 1,760
• Market Cap: 4.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	2.08B	718.48M	52.80%
Jun 30, 2024	1.36B	355.61M	35.38%
Jun 30, 2023	1.01B	-106.87M	-9.61%
Jun 30, 2022	1.11B	50.07M	4.71%
Jun 30, 2021	1.06B	51.61M	5.11%